{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:44:39Z","timestamp":1782485079359,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41440-018-0174-6","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:10:31Z","timestamp":1554419431000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications"],"prefix":"10.1038","volume":"42","author":[{"given":"Takuya","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"174_CR1","doi-asserted-by":"crossref","unstructured":"Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009; CD001841.","DOI":"10.1002\/14651858.CD001841.pub2"},{"key":"174_CR2","doi-asserted-by":"crossref","unstructured":"Wong GWK, Laugerotte A, Wright JM. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension (Review). Cochrane Database Syst Rev. 2015; CD007449.","DOI":"10.1002\/14651858.CD007449.pub2"},{"key":"174_CR3","doi-asserted-by":"crossref","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension (Review). Cochrane Database Syst Rev. 2017; CD002003.","DOI":"10.1002\/14651858.CD002003.pub5"},{"key":"174_CR4","first-page":"873","volume":"89","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Pre-ferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;89:873\u201380.","journal-title":"Ann Intern Med"},{"issue":"supple6","key":"174_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2165\/00003495-198800366-00015","volume":"36","author":"JJ McPhillips","year":"1988","unstructured":"McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study. Drugs. 1988;36(supple6):82\u201391.","journal-title":"Drugs"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0002-9149(91)90711-S","volume":"68","author":"RG Asmar","year":"1991","unstructured":"Asmar RG, Kerihuel JC, Girerd VJ, Safar ME. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension. Am J Cardiol. 1991;68:61\u201364.","journal-title":"Am J Cardiol"},{"key":"174_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00926239208412857","volume":"18","author":"CP Broekman","year":"1992","unstructured":"Broekman CP, Haensel SM, Van de Ven LL, Slob AK. Bisoprolol and hypertension: effects on sexual functioning in men. J Sex Marital Ther. 1992;18:325\u201331.","journal-title":"J Sex Marital Ther"},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/clc.4960170509","volume":"17","author":"ME Davidov","year":"1994","unstructured":"Davidov ME, Singh SP, Vlachakis ND, Blumenthal JB, Simon JS, Bryzinski BS. et al. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension. Clin Cardiol. 1994;17:263\u20138.","journal-title":"Clin Cardiol"},{"key":"174_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/j.1552-4604.1995.tb05009.x","volume":"35","author":"WH Frishman","year":"1995","unstructured":"Frishman WH, Burris JF, Mroczek WJ, Weir MR, Alemayehu D, Simon JS, et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995;35:182\u20138.","journal-title":"J Clin Pharmacol"},{"key":"174_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00004872-200204000-00037","volume":"20","author":"AJ Deary","year":"2001","unstructured":"Deary AJ, Schumann AL, Murfet H, Haydock SF, Foo RS, Brown MJDouble-blind. placebo-controlled crossover comparison of five classes of antihypertensive drugs. J Hypertens. 2001;20:771\u20137.","journal-title":"J Hypertens"},{"key":"174_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/cs1030493","volume":"103","author":"AJ Deary","year":"2002","unstructured":"Deary AJ, Schumann AL, Murfet H, Haydock S, Foo RS, Brown MJ. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci. 2002;103:493\u20139.","journal-title":"Clin Sci"},{"key":"174_CR12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1524-6175.2006.05696.x","volume":"8","author":"MA Weber","year":"2006","unstructured":"Weber MA, Barkris GL, Tarka EA, Iyengar M, Fleck R, Sica DA. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension. J Clin Hypertens. 2006;8:840\u20139.","journal-title":"J Clin Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0174-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:05Z","timestamp":1684617605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0174-6","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}